Double Star Tablet 40/5 mg

Adult dose

The recommended dosage is 1 tablet once daily, to be taken with water regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). - 40/5 mg: Administered to patients whose blood pressure is not adequately controlled with 5 mg of amlodipine or 40 mg of telmisartan. - 80/5 mg: Administered to patients whose blood pressure is not adequately controlled with 5 mg of amlodipine or this medication 40/5 mg.

Child dose

Safety and efficacy have not been established for pediatric patients under 18 years of age, so administration of this medication is not recommended.

This medication can cause serious harm to the fetus if used during pregnancy, particularly in the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. This medication should not be administered to patients with certain conditions, such as severe liver disease, heart valve problems, severe hypotension, or patients in an unstable condition post-acute myocardial infarction. Special caution is required for patients with primary aldosteronism, impaired liver function, gastrointestinal disorders, or issues with renal vasculature. Common side effects during treatment include dizziness and peripheral edema, and serious side effects may rarely occur; therefore, immediate consultation with healthcare providers is necessary if symptoms appear. It is vital not to use this medication during pregnancy, and if pregnancy is confirmed, it should be discontinued as soon as possible. Due to the risk of excessively low blood pressure, special care must be taken if fluids or salt are insufficient, and proper treatment should be sought immediately if signs of hypotension occur. Regular blood tests to monitor potassium levels are recommended, as this medication may increase serum potassium. Patients with renal problems should frequently check their kidney function before and during treatment, and caution is needed as there is limited experience using this medication in kidney transplant patients. During treatment, patients may experience dizziness or drowsiness when driving or operating dangerous machinery. There is potential for drug interactions, so any current medications should be disclosed to healthcare providers, particularly when taken alongside specific heart medications, diuretics, and analgesics. In case of overdose, symptoms such as low blood pressure, dizziness, and heart rhythm abnormalities may occur; immediate emergency treatment is necessary, and self-treatment should be avoided. This medication is not recommended for children due to the establishment of safety and efficacy being lacking. For the elderly, reactions to the medication may be more sensitive, so careful dose adjustment is recommended.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attack, respiratory issues accompanied by cough and fever, yellowing of the skin or eyes (jaundice), profound lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, urination changes.

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory tract infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• hypersensitivity
• hyperkalemia

This medication is sensitive to light and should be stored in a container that blocks light, at a temperature between 1°C and 30°C. Proper storage will help maintain the medication's effectiveness and prevent degradation.

Appearance

A double convex oval-shaped tablet that is white and light blue.

Package unit

30 tablets (10 tablets/PTP × 3), 30 tablets/bottle, 100 tablets/bottle